Belize vs Mauritania: Cause of death, by non-communicable diseases, ages 15-59
Belize
42.8%
in 2021
Mauritania
42.3%
in 2021
Belize rank
141st
Mauritania rank
143rd
Cause of death, by non-communicable diseases, ages 15-59 over time
- Belize
- Mauritania
How they compare
Belize currently reports 42.8% against 42.3% in Mauritania, a difference of 0.5%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Belize ahead.
Belize ranks 141st and Mauritania ranks 143rd of 185 countries.
Belize has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.0% | 35.7% | 8.3% | Belize |
| 2010s | 45.1% | 42.1% | 3.0% | Belize |
| 2020s | 44.5% | 41.8% | 2.7% | Belize |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Belize or Mauritania?
- Belize, at 42.8% against 42.3% in Mauritania as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Belize and Mauritania?
- 0.5%, with Belize ahead.
- How many years of comparable data are there for Belize and Mauritania?
- 6 years are reported by both, from 2000 to 2021.
- How do Belize and Mauritania rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Belize ranks 141st and Mauritania ranks 143rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.